Company intelligence / Profile preview

Aer Healthcare

Ownership: Private
Development stage: Commercial

Overview

Aer Healthcare is not engaged in pharmaceutical R&D. The UK entity provides residential care for learning difficulties, mental health, and substance abuse. In Australia, the brand offers at-home sleep testing services and supplies dental products.

Therapeutic areas: PsychiatryNeurology
Industry: Non-Academic Healthcare

Drug pipeline

1 asset

Aer Dorsal

Commercial

Indications: Obstructive sleep apnea, Snoring

Beyond the preview

Go deeper on Aer Healthcare.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Aer Healthcare.

Explore the full profile